ARTICLE | Clinical News
ANG1005: Phase II started
October 28, 2013 7:00 AM UTC
Angiochem began a U.S. Phase II trial to evaluate ANG1005 in up to 83 patients with recurrent high-grade glioma. Next quarter, Angiochem also plans to start a Phase II trial of ANG1005 in HER2-positiv...